Evidence map›Paper›PMID 25964989›Full record

ReviewBiochemistry2015

The Voltage-Gated Proton Channel: A Riddle, Wrapped in a Mystery, inside an Enigma.

Thomas E DeCoursey

Abstract readReview
In one paragraph

Review in Biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 50 citations in OpenAlex.

  1. Modulators of the Human Voltage-Gated Proton Channel HPharmaceuticals (Basel, Switzerland) · 2025
    Review
  2. Fluctuating hydrogen-bond network of the Hv1 ion channel.Computational and structural biotechnology journal · 2025
    Article
  3. Ion Channels in the Immune Response of Asthma.Journal of respiratory biology and translational medicine · 2024
    Article
  4. Quantitative insights into the mechanism of proton conduction and selectivity for the human voltage-gated proton channel Hv1.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Review
  6. Review
  7. Transcendent Aspects of Proton Channels.Annual review of physiology · 2024
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. The therapeutic importance of acid-base balance.Biochemical pharmacology · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Thomas E DeCourseyDepartment of Molecular Biophysics and Physiology, Rush University, 1750 West Harrison, Chicago, Illinois 60612, United States.
Rush University · US

Funding

Selectivity and Permeation in the Human Voltage-gated Proton Channel, hHv1R01GM102336 · NIGMS · RUSH UNIVERSITY MEDICAL CENTER · PI DECOURSEY, THOMAS E, SMITH, SUSAN M.E. · 2013 to 2016
$1.3M
Structure-Function Releationships of Voltage-Gated Proton ChannelsR01GM087507 · NIGMS · RUSH UNIVERSITY MEDICAL CENTER · PI DECOURSEY, THOMAS E · 2010 to 2013
$1.2M
NIGMS NIH HHS GM102336NIGMS NIH HHS R01 GM087507NIGMS NIH HHS R01 GM102336
6 · The paper itself

Abstract

The main properties of the voltage-gated proton channel (HV1) are described in this review, along with what is known about how the channel protein structure accomplishes its functions. Just as protons are unique among ions, proton channels are unique among ion channels. Their four transmembrane helices sense voltage and the pH gradient and conduct protons exclusively. Selectivity is achieved by the unique ability of H3O(+) to protonate an Asp-Arg salt bridge. Pathognomonic sensitivity of gating to the pH gradient ensures HV1 channel opening only when acid extrusion will result, which is crucial to most of its biological functions. An exception occurs in dinoflagellates in which influx of H(+) through HV1 triggers the bioluminescent flash. Pharmacological interventions that promise to ameliorate cancer, asthma, brain damage in ischemic stroke, Alzheimer's disease, autoimmune diseases, and numerous other conditions await future progress.

Indexed as

AnimalsDrug DiscoveryHumansHydrogen-Ion ConcentrationIon Channel GatingIon ChannelsModels, MolecularProtein ConformationProtonsHVCN1 protein, humanIon ChannelsProtons

Identifiers

PMID25964989
PMCPMC4736506
OpenAlexW329176578

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.